Parameiosis in Aspergillus nidulans in response to doxorubicin

Folia Microbiologica

Volumn 49, Issue 6, 2004, Pages 699-704

  Becker, T C A ^a   De Castro Prado, M A A ^a  

^a STATE UNIVERSITY OF MARINGÁ   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

ASPERGILLUS; EMERICELLA NIDULANS;

EID: 17444380489     PISSN: 00155632     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF02931552     Document Type: Article

References (22)

1. ALY M.S., OTHMAN O.E., EL NAHAS S.M.: Specific numerical chromosomal aberrations induced by adriamycin. Environ.Mol.Mutagen 33, 161-166 (1999).
2. BAGULEY B.C., FERGUSON L.R.: Mutagenic properties of topoisomerase- targeted drugs. Biochim.Biophys.Acta 1400, 213-222 (1998).
3. BAPTISTA F., MACHADO M.F.P.S., DE CASTRO-PRADO M.A.A.: Alternative reproduction pathway in Aspergillus nidulans. Folia Microbiol. 48, 597-604 (2003).
4. BECKER T.C.A., CHIUCHETTA S.J.R., BAPTISTA F., DE CASTRO-PRADO M.A.A.: Increase in mitotic recombination in diploid cells of Aspergillus nidulans in response to ethidium bromide. Gen.Mol.Biol. 26, 381-385 (2003).
5. BELLO V.A., PACCOLA-MEIRELLES L.D.: Localization of auxotrophic and benomyl resistance markers through the parasexual cycle in the Beauveria bassiana (BALS) vuil entomopathogen. J.Invert.Pathol. 72, 199-225 (1998).
6. BOEGE F.: Analysis of eukaryotic DNA topoisomerases and topoisomerase-directed drug effects. Eur.J.Clin.Chem.Biochem. 34, 873-888 (1996).
7. CHABNER B.A., ALLEGRA C.J., CURT G.A., CALABRESI P.: Antineoplastic agents, pp. 1233-1287 in P.B. Molinoff, R.W. Ruddon (Eds): The Pharmacological Basis of Therapeutics, 9th ed. McGraw-Hill, New York 1996.
8. + and uvsH//uvsH diploid strain of Aspergillus nidulans. Folia Microbiol. 45, 516-520 (2002).
9. ESPOSITO R.E, HOLLIDAY R.: The effect of 5-fluorodeoxyuridine on genetics replication and mitotic crossing-over in synchronized cultures of Ustilago maydis. Genetics 50, 1009-1017 (1964).
10. Fox G., POPANDA O., EDLER L., THIELMANN H.W.: Preferential inhibition of DNA polymerases α, δ, and ε from Novikoff hepatoma cells by inhibitors of cell proliferation. J.Cancer Res.Clin.Oncol. 122, 78-94 (1996).
11. FROELICH J.J., SCHNELLER F.R.J., ZAHN R.K.: The influence of radiation and chemotherapy-related DNA strand break on carcinogenesis: an evaluation. Clin.Chem.Lab.Med. 37, 403-408 (1999).
12. GORBSKY G. J.: Cells cycle progression and chromosome segregation in mammalian cells cultured in the presence of the topoisomerasell inhibitors ICRF-187 [(+)-1,2-bis(3,5-dioxopiperazin-1-yl)propane; ADR-529] and ICRF-159 (razoxane). Cancer Res. 54, 1042-1048 (1994).
13. HACKER-KLOM U.B., MEISTRICH M.L., GÖHDE W.: Effects of doxorubicin and 4′-epi-doxorubicin on mouse spermatogenesis. Mut.Res. 160, 39-46 (1986).
14. HOLLIDAY R.: The induction of mitotic recombination by mitomycin C in Ustilago and Saccharomyces. Genetics 50, 323-335 (1964).
15. KALLIO M., LÄHDETIE J.: Fragmentation of centromeric DNA and prevention of homologous chromosome separation in male mouse meiosis in vivo by the topoisomerase II inhibitor etoposide. Mutagen 11, 435-443 (1996).
16. LEHMANN M., FRANCO A., VILAR K.S.P., REGULY M.L., ANDRADE H.H.R.: Doxorubicin and two of its analogues are preferential inducers of homologous recombination compared with mutational events in somatic cells of Drosophila melanogaster. Mut.Res. 539, 167-175 (2003).
17. MÜLLER I., JENNER A., BRUCHELT G., NIETHAMMER D., HALLIWELL B.: Effects of concentration on the cytotoxic mechanism of doxorubicin-apoptosis and oxidative DNA damage. Biochem.Biophys.Res.Commun. 230, 254-257 (1997).
18. PONTECORVO G., ROPER J. A., HEMMONS L.M., MACDONALD K.D., BUFTON A.D.: The genetics of Aspergillus nidulans. Adv.Genet. 5, 141-238 (1953).
19. POTTER A.J., GOLLAHON K.A., PALANCA B.J., HARBERT M.J., CHOI Y.M., MOSKOVITIZ A.H., POTTER J.D., RABINOVITCH P.S.: Flow cytometric analysis of the cells cycle phase specificity of DNA damage induced by radiation, hydrogen peroxide and doxorubicin. Carcinogen 23, 389-401 (2002).
20. SNYDERS R.D., ARNONE M.R.: Putative identification of functional interaction between DNA-intercalating agents and topoisomerase II using the V79 in vitro micronucleus assay. Mut.Res. 503, 21-35 (2002).
21. VAN DE VATE C., JANSEN G.J.O.: Meiotic recombination in a duplication strain of Aspergillus nidulans. Gen.Res. 31, 29-52 (1978).
22. WASSERMANN K., MOLGAARD K., STEINESS E.: Similar changes in cardiac morphology and DNA synthesis induced by doxorubicin and 4′-epi- doxorubicin. Cancer Chemother.Pharmacol. 15, 244-252 (1985).